PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)

PHASE4UnknownINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

December 31, 2023

Conditions
Streptococcus Pneumonia
Interventions
BIOLOGICAL

PPV23

random allocation 1:1:1 IM injection

BIOLOGICAL

PCV13

random allocation 1:1:1 IM injection

OTHER

Saline for injection

random allocation 1:1:1 IM injection

Trial Locations (1)

Unknown

RECRUITING

Liverpool School of Tropical Medicine, Liverpool

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Liverpool School of Tropical Medicine

OTHER